Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder that affects approximately 10-15% of the global population. It is characterized by chronic abdominal pain, bloating, and altered bowel habits, significantly impacting patients' quality of life.
Diagnosis primarily relies on the Rome IV criteria, which includes recurrent abdominal pain for at least one day per week in the last three months, associated with two or more of the following: related to defecation, change in stool frequency, or change in stool form.
Management of IBS requires a multi-faceted approach. Lifestyle modifications such as regular exercise, adequate sleep, and stress management are beneficial. Dietary modifications including low-FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) diet have shown promising results. Pharmacologic treatments include antispasmodics, probiotics, and antidepressants.
Cognitive-behavioral therapy (CBT) and hypnotherapy are useful adjuncts in managing IBS, particularly in patients with associated psychological comorbidities.
Effective management of IBS requires a comprehensive, patient-centered approach. Further research is needed to refine these strategies and improve patient outcomes.
1.
Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'
2.
Renewing the call for a national Cancer Patient's Bill of Rights
3.
Woman Loses 6-Year Battle With Mouth Tumor
4.
Pressing the Sleep button could have a positive impact on cognition.
5.
FDA Approves Iberdomide Combo for Multiple Myeloma
1.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Polycythemia Vera: A Historical Perspective and Contemporary Management
4.
ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring
5.
Prevention Through Survivorship-Focused Strategies for Preserving Functional Independence After Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
The Role of Platelets in Normal Blood Clotting
4.
Comprehensive Update on Hematology
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation